newsfilter
← Latest News
GlobeNewswire·

Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering

WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (NASDAQ:MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today